Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer

MLA

Hikmat Abdel-Razeq, et al. “Treatment Strategies for Residual Disease Following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer.” Current Oncology, vol. 29, no. 8, Aug. 2022, pp. 5810–22. EBSCOhost, https://doi.org/10.3390/curroncol29080458.

APA

Hikmat Abdel-Razeq, Hanan Khalil, Hazem I. Assi, & Tarek Bou Dargham. (2022). Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer. Current Oncology, 29(8), 5810–5822. https://doi.org/10.3390/curroncol29080458

Chicago

Hikmat Abdel-Razeq, Hanan Khalil, Hazem I. Assi, and Tarek Bou Dargham. 2022. “Treatment Strategies for Residual Disease Following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer.” Current Oncology 29 (8): 5810–22. doi:10.3390/curroncol29080458.